PSOGEN:Effect adalimumab op zelfbeeld en seksueel functioneren bij matige en ernstige psoriasis van de anogenitale regio; prospectief, open label pilot onderzoek

Phase 4

Recruiting

• Conditions: Psoriasis; scaling skin condition; 10014982

• Registration Number: NL-OMON33188
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

-Having psoriasis of the anogenital region
-The patient will be treated with adalimumab by attending physician

Exclusion Criteria

-Younger than 18
-Homosexual
-Unwilling to participate

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Lower scores on the measuring questionnaires.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None</p><br>